Clinical trial / 2010
Consuming hibiscus tea daily for 6 weeks significantly lowered systolic blood pressure in prehypertensive and mildly hypertensive adults.
A randomized, double-blind, placebo-controlled trial evaluated the effects of consuming 3 240-mL servings/d of brewed Hibiscus sabdariffa tea versus a placebo beverage for 6 weeks in 65 pre- and mildly hypertensive adults. At 6 weeks, hibiscus tea lowered systolic BP significantly more than placebo (-7.2 +/- 11.4 vs. -1.3 +/- 10.0 mm Hg; P = 0.030). Diastolic BP change did not significantly differ between groups (-3.1 +/- 7.0 vs. -0.5 +/- 7.5 mm Hg; P = 0.160), while mean arterial pressure showed borderline significance (-4.5 +/- 7.7 vs. -0.8 +/- 7.4 mm Hg; P = 0.054). Participants with higher baseline systolic BP showed a greater response to hibiscus tea (r = -0.421; P = 0.010).
- Study type
- Randomized, double-blind, placebo-controlled clinical trial
- Who was studied
- 65 pre- and mildly hypertensive adults aged 30-70 years not taking blood pressure-lowering medications
- What was measured
- Systolic, diastolic, and mean arterial blood pressure measured weekly over 6 weeks
THE PAPER
Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults.
McKay DL, Chen CY, Saltzman E, Blumberg JB. J Nutr, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.